期刊文献+

Stargardt病的临床和治疗观察

Clinical and therapeutical observation of Stargardt′s disease
下载PDF
导出
摘要 目的观察Stargardt病的临床表现及其有意义的治疗。方法通过眼科常规检查及FFA、P-VEP和F-ERG等特殊检查分析本病特点,并给予中药治疗,观察治疗前后患者视力、P100振幅与潜伏期时值的改变。结果42眼中30眼视力0.1~0.3,眼底黄斑部有典型的金箔样反光,多有近视且视力不能矫正。FFA示萎缩区透见荧光,可有脉络膜湮没症;P100振幅明显降低,潜伏期轻度中度延迟;F-ERG多正常,闪烁光ERG振幅降低;治疗后视力提高,P100振幅改善。结论对Stargardt病的黄斑部典型金箔样反光、FFA、P-VEP和F-ERG检查是有价值的诊断,四物五子汤等中药有治疗意义。 OBJECTIVE To investigate the clinical characters and significative treatment of Stargardt's disease.METHODS Twenty - one patients(42 eyes)with Stargardt's disease were tested with general check - up of ophthalmology. FFA and F- ERG performed in partial patients, and treated with Siwu Wuzi decoction( 四物五子汤)for 1 to 3 months. RESULTS The visual acuities of thirty eyes were 0.1 to 0.3. The typical copper color was found in the macular lesion of ocular fundus. On fluorescein angiography, window defect - hyperfluorescence was revealed. Choroidal silence sign was found in 53 % cases. Abnormity was revealed by P- VEP and Flicker- ERG. The visual acuity and P- VEP were improved. CONCLUSIONS Copper color in the macular lesion of ocular fundus, P - VEP, FFA and Flicker - ERG had diagnostic values. Siwu Wuzi decoction was effective to treat Stargardt's disease.
出处 《中国中医眼科杂志》 2007年第3期131-133,共3页 China Journal of Chinese Ophthalmology
关键词 STARGARDT病 四物五子汤 治疗 Stargardt's disease Siwu Wuzi decoction(四物五子汤)
  • 相关文献

参考文献10

二级参考文献12

  • 1陈有信,叶俊杰.吲哚青绿脉络膜血管造影Ⅱ.临床应用[J].中华眼底病杂志,1994,10(4):256-258. 被引量:5
  • 2Aaberg TM.Stargardt's disease and fundus flavimaculatus:evaluation of morphologic progression and intrafamilial co-existence.Trans Am Ophthalmol Soc,1986,84:453-487
  • 3Sieple WH,Siegel IM,Carr RE,et al.Evaluating macular function using the focal ERG.Invest Ophthalmol,1986,27:1123-1130
  • 4Noemi L,Graham EH,Catey B,et al.Phenotypic Subtypes of Stargardt Macular Dystrophy-Fundus Flavimaculatus.Arch Ophthalmol,2001,119:359-369
  • 5John DA,David M,Shizhao X,et al.Long-term follow-up of Stargardt's disease and fundus flavimaculatus.Ophthalmology,1998,105:448-458
  • 6Fishman CA,Father M,Patel BS,Visual acuity loss in patient with Stargardt's macular dystrophy.Ophatalmol,1987,94:809-914.
  • 7Noble KG,Carr RE,Stargardt's disease and fundus flavimaculatus.Arch Ophthalmol,1979,97:1281-1285.
  • 8Bonnin P,Le signe du silence choroidien dans les degenerescence tapeto-retinicannies centrales examinees sous fluoresceine.Bull Soe Ophthalmol Fr,1971,71:348-351.
  • 9Delori FC,Staurenghi G,Arend O,et al.vivo measurement of lipofusin in Stargardt's disease fundus flavimaculatus.Invest Ophthaimol Vis Sei,1995,36:2327-2331.
  • 10Wroblewski JJ,Gitter KA,Cohen G,Indocyanine green angiography in Stargardt's flavimaculatus.Am J Ophthalmol,1995,120:208-218.

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部